Marketable Securities, Current in USD of Enliven Therapeutics, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Enliven Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2022 to Q3 2025.
Enliven Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $376M, a 96.6% increase year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Enliven Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$376M	+$185M	+96.6%	Sep 30, 2025	10-Q	2025-11-12
Q2 2025	$371M	+$156M	+72.2%	Jun 30, 2025	10-Q	2025-08-13
Q1 2025	$188M	+$16.5M	+9.64%	Mar 31, 2025	10-Q	2025-05-14
Q4 2024	$189M	+$36.3M	+23.7%	Dec 31, 2024	10-Q	2025-11-12
Q3 2024	$191M	+$1.58M	+0.83%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$216M	+$63.4M	+41.6%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$171M			Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$153M	+$153M		Dec 31, 2023	10-K	2025-03-13
Q3 2023	$190M			Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$152M			Jun 30, 2023	10-Q	2023-08-10
Q4 2022	$0			Dec 31, 2022	10-K	2024-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.